Overview

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The objective is to determine if neuraminidase inhibition with zanamivir is efficacious as a therapeutic strategy to restore endothelial function in T2D patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Missouri-Columbia
Treatments:
Zanamivir